Economic Impact of Recurrent Clostridioides difficile Infection in the USA: A Systematic Literature Review and Cost Synthesis
KR Reveles, M Yang, V Garcia-Horton, ML Edwards… - Advances in …, 2023 - Springer
Introduction Up to 35% of patients with a first episode of Clostridioides difficile infection (CDI)
develop recurrent CDI (rCDI), and of those, up to 65% experience multiple recurrences. A …
develop recurrent CDI (rCDI), and of those, up to 65% experience multiple recurrences. A …
Healthcare resource utilization and direct medical costs associated with index and recurrent Clostridioides difficile infection: a real-world data analysis
P Feuerstadt, L Stong, DN Dahdal… - Journal of medical …, 2020 - Taylor & Francis
Aims: This study aimed to evaluate all-cause economic outcomes, healthcare resource
utilization (HRU), and costs in patients with Clostridioides difficile infection (CDI) and …
utilization (HRU), and costs in patients with Clostridioides difficile infection (CDI) and …
A systematic review of real-world healthcare resource use and costs of Clostridioides difficile infections
DC Malone, EP Armstrong, D Gratie… - Antimicrobial …, 2023 - cambridge.org
Objective: To conduct a systematic review of published real-world evidence describing the
cost and healthcare resource use for Clostridiodes difficile infection (CDI) in the United …
cost and healthcare resource use for Clostridiodes difficile infection (CDI) in the United …
Health care resource utilization and costs of recurrent Clostridioides difficile infection in the elderly: a real-world claims analysis
WW Nelson, TA Scott, M Boules, C Teigland… - Journal of Managed …, 2021 - jmcp.org
BACKGROUND: Clostridioides difficile infection (CDI) affected an estimated 365,000
persons in the United States in 2017. Despite a nationally decreasing trend of CDI cases …
persons in the United States in 2017. Despite a nationally decreasing trend of CDI cases …
Clinical burden of recurrent Clostridioides difficile infection in the medicare population: a real-world claims analysis
P Feuerstadt, WW Nelson, C Teigland… - Antimicrobial …, 2022 - cambridge.org
Objective: To describe 12-month outcomes for beneficiaries in the 100% Medicare Fee-for-
Service (FFS) population with primary and recurrent Clostridioides difficile infection (CDI) …
Service (FFS) population with primary and recurrent Clostridioides difficile infection (CDI) …
Attributable costs and length of stay of hospital-acquired Clostridioides difficile: A population-based matched cohort study in Alberta, Canada
Objective: To determine the attributable cost and length of stay of hospital-acquired
Clostridioides difficile infection (HA-CDI) from the healthcare payer perspective using linked …
Clostridioides difficile infection (HA-CDI) from the healthcare payer perspective using linked …
Healthcare resource use and attributable cost of Clostridium difficile infection: a micro-costing analysis comparing first and recurrent episodes
R Tresman, SD Goldenberg - Journal of Antimicrobial …, 2018 - academic.oup.com
Objectives Accurate and sufficiently detailed data on the economic burden of Clostridium
difficile infection (CDI) are lacking. We performed a micro-costing study to determine the …
difficile infection (CDI) are lacking. We performed a micro-costing study to determine the …
A comprehensive study of costs associated with recurrent Clostridium difficile infection
R Rodrigues, GE Barber… - infection control & …, 2017 - cambridge.org
BACKGROUND Clostridium difficile infection (CDI) is the most common healthcare-
associated infection and is associated with considerable morbidity. Recurrent CDI is a key …
associated infection and is associated with considerable morbidity. Recurrent CDI is a key …
Estimating excess mortality and economic burden of Clostridioides difficile infections and recurrences during 2015–2019: the RECUR Germany study
A Antunes, A Tricotel, A Wilk, S Dombrowski… - BMC Infectious …, 2024 - Springer
Abstract Background Clostridioides difficile infections (CDIs) and recurrences (rCDIs) remain
a major public health challenge due to substantial mortality and associated costs. This study …
a major public health challenge due to substantial mortality and associated costs. This study …
Costs Attributable to Clostridioides difficile Infection Based on the Setting of Onset
JM Sahrmann, MA Olsen, D Stwalley… - Clinical Infectious …, 2023 - academic.oup.com
Abstract Background Although hospital-onset Clostridioides difficile infection (CDI) is
associated with significant healthcare costs, the economic burden of CDI with onset in other …
associated with significant healthcare costs, the economic burden of CDI with onset in other …